Duloxetine: An emerging evidence for fibromyalgia

Biomedicine and Pharmacotherapy

Volumn 63, Issue 1, 2009, Pages 69-71

  Pae, Chi Un ^a,b   Marks, David C ^b   Han, Changsu ^b,c   Patkar, Ashwin A ^b   Masand, Prakash S ^d  

^a The Catholic University of Korea   (South Korea)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Korea University   (South Korea)

^d SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DULOXETINE; FLUOXETINE; MILNACIPRAN; PAROXETINE; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL FEATURE; CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; DRUG APPROVAL; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; FIBROMYALGIA; HUMAN; LETTER; MENTAL DISEASE; NEUROPATHIC PAIN; NEUROTRANSMISSION; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SEX DIFFERENCE; UNSPECIFIED SIDE EFFECT;

ANALGESICS; ANTIDEPRESSIVE AGENTS; CYCLOPROPANES; FIBROMYALGIA; GAMMA-AMINOBUTYRIC ACID; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THIOPHENES;

EID: 58049156043     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.03.011     Document Type: Letter

References (20)

1. Ackenheil M. Genetics and pathophysiology of affective disorders: relationship to fibromyalgia. Z Rheumatol 57 Suppl. 2 (1998) 5-7
2. Offenbaecher M., Glatzeder K., and Ackenheil M. Self-reported depression, familial history of depression and fibromyalgia (FM), and psychological distress in patients with FM. Z Rheumatol 57 Suppl. 2 (1998) 94-96
3. Arnold L.M., Rosen A., Pritchett Y.L., D'Souza D.N., Goldstein D.J., Iyengar S., et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 119 1-3 (2005 Dec 15) 5-15
4. Arnold L.M., Keck Jr. P.E., and Welge J.A. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 41 2 (2000 Ma-Apr) 104-113
5. Arnold L.M., Hess E.V., Hudson J.I., Welge J.A., Berno S.E., and Keck Jr. P.E. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 112 3 (2002 Feb 15) 191-197
6. O'Malley P.G., Balden E., Tomkins G., Santoro J., Kroenke K., and Jackson J.L. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 15 9 (2000 Sep) 659-666
7. Patkar A.A., Masand P.S., Krulewicz S., Mannelli P., Peindl K., Beebe K.L., et al. A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am J Med 120 5 (2007 May) 448-454
8. Goldenberg D., Mayskiy M., Mossey C., Ruthazer R., and Schmid C. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 39 11 (1996 Nov) 1852-1859
9. Wolfe F., Cathey M.A., and Hawley D.J. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 23 5 (1994) 255-259
10. Anderberg U.M., Marteinsdottir I., and von Knorring L. Citalopram in patients with fibromyalgia-a randomized, double-blind, placebo-controlled study. Eur J Pain 4 1 (2000) 27-35
11. Norregaard J., Volkmann H., and Danneskiold-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 61 3 (1995 Jun) 445-449
12. Vitton O., Gendreau M., Gendreau J., Kranzler J., and Rao S.G. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 19 Suppl. 1 (2004 Oct) S27-S35
13. Gendreau R.M., Thorn M.D., Gendreau J.F., Kranzler J.D., Ribeiro S., Gracely R.H., et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 32 10 (2005 Oct) 1975-1985
14. Arnold L.M., Lu Y., Crofford L.J., Wohlreich M., Detke M.J., Iyengar S., et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50 9 (2004 Sep) 2974-2984
15. Galer B.S., Gianas A., and Jensen M.P. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 47 2 (2000 Feb) 123-128
16. Arnold L.M., Pritchett Y.L., D'Souza D.N., Kajdasz D.K., Iyengar S., and Wernicke J.F. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials(2002). J Women Health 16 8 (2007 Oct) 1145-1156
17. FDA. FDA Approves First Drug for Treating Fibromyalgia. [cited; Available from: (2007). http://www.fda.gov/bbs/topics/NEWS/2007/NEW01656.html
18. King S.J., Wessel J., Bhambhani Y., Sholter D., and Maksymowych W. Predictors of success of intervention programs for persons with fibromyalgia. J Rheumatol 29 5 (2002 May) 1034-1040
19. Turk D.C., Okifuji A., Sinclair J.D., and Starz T.W. Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment. Arthritis Care Res 11 5 (1998 Oct) 397-404
20. Robinson R.L., Birnbaum H.G., Morley M.A., Sisitsky T., Greenberg P.E., and Wolfe F. Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently. J Rheumatol 31 8 (2004 Aug) 1621-1629